This brand name is authorized in Australia, Cyprus, Ecuador, Estonia, Finland, France, Malta, Netherlands, Singapore, Tunisia, Turkey, South Africa
The drug COVERAM contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Perindopril
UNII TFT5IM1KGB - PERINDOPRIL ARGININE
|
|
Perindopril is an inhibitor of the enzyme that converts angiotensin I into angiotensin II (Angiotensin Converting Enzyme ACE). The converting enzyme, or kinase, is an exopeptidase that allows conversion of angiotensin I into the vasoconstrictor angiotensin II as well as causing the degradation of the vasodilator bradykinin into an inactive heptapeptide. Inhibition of ACE results in a reduction of angiotensin II in the plasma, which leads to increased plasma renin activity (by inhibition of the negative feedback of renin release) and reduced secretion of aldosterone. Since ACE inactivates bradykinin, inhibition of ACE also results in an increased activity of circulating and local kallikrein-kinin systems (and thus also activation of the prostaglandin system). |
|
2
Amlodipine
UNII 864V2Q084H - AMLODIPINE BESYLATE
|
|
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| COVERAM Tablet | Pharmaceutical Benefits Scheme (AU) | MPI, EU: SmPC | |
| COVERAM Tablet | Medicines Authority (MT) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C09BB04 | Perindopril and amlodipine | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09B ACE inhibitors, combinations → C09BB ACE inhibitors and calcium channel blockers |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 9346X, 9347Y, 9348B, 9349C |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 29453-11-10, 29455-11-10, 29471-11-10, 29472-11-10 |
| Country: EE | Ravimiamet | Identifier(s): 1288616, 1288627, 1288638, 1288649, 1288650, 1288661, 1288672, 1288683, 1288694, 1288706, 1288717, 1288728, 1288739, 1288740, 1288751, 1288762, 1288773, 1288784, 1288795, 1288807, 1288818, 1288829, 1288830, 1288841, 1288852, 1288863, 1288874, 1288885, 1288896, 1288908, 1288919, 1288920, 1288931, 1288942, 1288953, 1288964, 1288975, 1288986, 1288997, 1289000, 1289011, 1289022, 1289044, 1289055, 1289066, 1289077, 1289088, 1289099, 1289101, 1289112, 1289123, 1289134, 1289145, 1289156, 1289167, 1289178, 1766099, 1766101, 1766112, 1766123 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 153352, 153363, 153374, 153385, 153396, 153407, 153418, 153430 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60187348, 60367022, 60473812, 60660655, 60972480, 61515189, 62216243, 64441025, 65401119, 66159149, 66299756, 66473203, 67126052, 67753553, 69056122, 69163754 |
| Country: MT | Medicines Authority | Identifier(s): MA066/01501, MA066/01502, MA066/01503, MA066/01504 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 123382, 123390, 123404, 123412 |
| Country: SG | Health Sciences Authority | Identifier(s): 13826P, 13827P, 13828P, 13829P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6353161, 6353162, 6353163, 6353164 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699552010616, 8699552010623, 8699552010630, 8699552010647, 8699552091059, 8699552091066, 8699552091073 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 43/7.1.3/0933, 43/7.1.3/0934, 43/7.1.3/0935, 43/7.1.3/0936 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
